Jamaicas Oil Drilling Prospects Balancing Energy Independence and Climate Pledges Micron Stock Surges as UBS Triples Price Target on AI Memory Demand Park Medi World Reaches Record High After Acquisition Update Stock Gains Over 80 So Far This Year Caribbean Campaigners Raise Concerns Over Foreign Developer Access to Coastlines in Barbuda Grenada Jamaica AnheuserBusch InBev Shares Dip as Quarterly Sales Fall Short of Analyst Expectations Eli Lilly Edges Higher on Nearly 4B Vaccine Deal Expansion Scienture Holdings Inc SCNX Q1 2026 Earnings EPS Surprise of 64 Narrows Loss Amid Strategic Progress Beneficient BENF Q1 2026 Earnings Stellar EPS Surprise Amid Revenue Discretion Highlights Financial Resilience ENS Q1 2026 Earnings EPS Beats Estimates but Stock Slips Mastercard Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Uncertainty Stock Slips Lotus Technology Inc LOT Q3 2025 Earnings Loss Per Share Reported Amid Limited Analyst Coverage Mesabi Trust MSB Q1 2026 Earnings Iron Ore Royalty Income Pressures Net Income Shares Decline flyExclusive Inc FLYX Posts 313 Gain as Shares Test Resistance Near MultiWeek Highs PennyMac Mortgage Investment Trust PMT Holds Steady Near Support as Interest Rate Outlook Shifts Kyndryl Holdings Sees Modest Gain as Resistance Test Approaches EDD Gains 11 as Emerging Market Debt Fund Approaches Key Resistance Snowflake SNOW Surges 38 After Earnings Key Levels to Watch After the Breakout Marathon Petroleum MPC Pulls Back Amid Broader Energy Weakness Pinnacle Financial Partners PNFP Holds Near 97 Amid Narrow Trading Range Ethan Allen Interiors ETD Holds Steady Near 1974 as Support and Resistance Levels Come into Focus Chimera Investment Corporation CIM Holds Steady Near Support as Volume Normalizes Chime Financial CHYM Faces Resistance Pressure as Stock Declines 178 XOMAP Holds Steady at 2543 as Preferred Stock Maintains Parity EU Green Economy Surges Solar Energy Expansion at Record Pace Expro Group Holdings XPRO Q1 2026 Earnings GAAP Shortfall Amid Subsea Activity Momentum Trevi Therapeutics TRVI Holds Near Resistance After Modest Gain